Mumbai: Researchers in a Mumbai hospital hadreported presence of a multi-drug resistant superbug in anarticle published in an Indian medical journal, months before the Lancet study that has caused an outrage in the country`s medical fraternity and drawn criticism from the government.A team of researchers from Department of Medicine at P D Hinduja National Hospital and Medical Research Centre -- Payal Deshpande, Camilla Rodrigues, Anjali Shetty, Farhad Kapadia, Ashit Hedge and Rajeev Soman -- had in March this year warned about the superbug in the Journal of the Association of Physicians of India (JAPI).
"Microbes cannot be named after a city or a country andit is fundamentally wrong to name a microbe as New Delhimetallo-lactamase-1 (NDM-1). We should have objected last yearwhen the British scientists gave the nomenclature," he said."Methicillin-resistant Staphylococcus aureus (MRSA), abacterium responsible for several difficult-to-treatinfections in humans, was discovered in the UK, but it wasnot named after Kettering, UK," he said criticising thetendency to blame any country for emergence of superbugs.A study conducted by Dr Jean Louis Vincent and colleaguesof Erasme University Hospital in Brussels published in theDecember 2009 edition of the Journal of the American MedicalAssociation said heavy use of antibiotics in ICUs can makesuch units into epicentres for bacteria to mutate into drug-resistant forms and spread.Sanjay Borude, bariatric surgeon at the Breach CandyHospital, who performs weight loss procedures across thecountry and abroad, stressed the need for exhaustive researchon this issue and termed the Lancet study as a haphazardlydone survey."Having personally operated on more than 200 patientsfrom various countries abroad, I can safely vouch for the factthat not a single complication has ever occurred (due tosuperbugs)," Bourde said. He called for adherence to arational antibiotic policy in all hospitals.The Lancet study on NDM1 superbug came in for sharpcriticism by India which said there was the need to find outwhether there were "ulterior motives" behind the claim as ithad been funded by a pharmaceutical major. "The study was funded by a pharmaceutical company whichis one of the biggest antibiotics makers in the world," UnionHealth Minister Ghulam Nabi Azad had said yesterday reactingto the report.PTI
New generation of drugs to cure hepatitis C
Australia corals to light up cancer cure fight